A carregar...
Incidence and relative risk of peripheral neuropathy in cancer patients treated with eribulin: a meta-analysis
BACKGROUND: Eribulin is a microtubule inhibitor, which is approved for the treatment of breast cancer. Peripheral neuropathy has been reported in the studies of eribulin, but the incidence and relative risk (RR) of eribulin-associated peripheral neuropathy varied greatly in cancer patients. The purp...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5762380/ https://ncbi.nlm.nih.gov/pubmed/29340112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21057 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|